Schizophrenia and Disorders with Psychotic Features MOAs

Schizophrenia and Disorders with Psychotic Features	Welcome, Profile Billing Logout

Schizophrenia and Disorders with Psychotic Features

Welcome, Profile Billing Logout


Phase N/A 1 2 3 4 Products	0	3	6	9	12	15	18	21	24	27	30



Dopamine agon




Serotonin 2C receptor agon




Histamine H1 receptor antag




IFNα stim




Glycine transporter 1 inhib




Serotonin 1A receptor partial agon




Cannabinoid receptor 1 agon




IFNα stim




NMDAR antag




PPAR γ agon




α1 adrenergic receptor antag




GABA A receptor agon




Na+ channel antag




PDE10 inhib




Progesterone receptor antag




α7 nicotinic acetylcholine receptor agon




AChE inhib




AMPA receptor agon




Cannabinoid receptor 2 antag




Decarboxylase inhib




GCR II antag




Glutamate receptor antag




IL-1 inhib




IL-6 mod




Norepinephrine reuptake inhib




Nucleoside guanosine analog




Tubulin polymerization inhib




Voltage-gated sodium channel inhib




AGRP inhib




AMPK activator




AMPK activator




Adenosine A2A receptor antag




Adenosine A2A receptor antag




Angiotensin II blocker




Apoptosis inducer




Apoptosis stim




CACNA2D1 protein mod




COX2 inhib




Ca2+ channel antag




Carbonic anhydrase inhib




Catechol O methyltransferase inhib




Cell cycle inhib




DGAT inhib




DPP4 inhib




EEF1A2 inhib




Estrogen receptor agon




Fatty acid inhib




GLP-1 receptor agon




HMG-CoA reductase inhib




Histamine H1 receptor agon



	Diseases Companies Products Productz Mechanisms of Action Sites